Advertisement
Persons > Switzerland
Find below all kinds of persons from Switzerland (Schweiz / Suisse).Total search results: 1247 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13
Person | Position | Organisation (Group) | Region |
---|---|---|---|
Gottschalk, Uwe (Keensight Capital 202201– Operating Partner before Lonza + Sartorius + Bayer) | Partner (venture partner) | Keensight Capital S.A.S. | Île-de-France (region) |
Goundis, Dimitri (MaxiVax 201602– CEO before Acrongenomics + Speedel + Medicines Co Inc + Roche) | Chief Executive Officer (CEO) | MaxiVax S.A. | Région Lémanique (region) |
Grabulovski, Dragan (Bellevue 202109– Venture Partner at Pureos Bioventures before Covagen CSO + co-founder) | Partner (venture partner) | Bellevue (Group) | Channel Islands (Non-Commonwealth / Non-EU tax haven) |
Graf-Tschupp, Nathalie (Alentis Therapeutics 202111 Officer Manager) | n. a. | Alentis Therapeutics AG | Northwestern Switzerland (region) |
Graham, Peter (ADC Therapeutics 202211– Chief Legal Officer before Halozyme Therapeutics + Delcath Systems) | General Counsel / Chief Legal Officer (CLO) | ADC Therapeutics (Group) | Région Lémanique (region) |
Graham, Teresa (Roche 202307 CEO of Roche Pharma) | Chief Executive Officer (CEO) | Roche (Group) | Northwestern Switzerland (region) |
Gramatica, Ruggero (Therametrics –201309 CEO RESIGNED 9/13) | Chief Executive Officer (CEO) | Relief Therapeutics (Group) | Central Switzerland (region) |
Grandidier, Laurent (Xeltis 201412 CEO) | Chief Executive Officer (CEO) | Xeltis (Group) | Zürich (region) |
Graney, Tom (Oxurion 202105– CEO joined as CFO 10/20 before Generation Bio + Vertex Pharma + Ironwood Pharma + JnJ) | Chief Executive Officer (CEO) | Oxurion (Group) | Belgium_o |
Grau, Michael (Kuros 202209 CFO before Proteros + Correvio + Ingenium + MorphoSys) | Chief Financial Officer (CFO) | Kuros (Group) | Zürich (region) |
Grawunder, Ulf (T-Curx 202210– CEO + Co-Founder before NBE Therapeutics + 4-Antibody) | Chief Executive Officer (CEO) | T-Curx GmbH | Bayern (federal state) |
Griebel, Ralf (Tecan 202102 Head Partnering Business) | Business Development Manager / Strategy Manager | Tecan (Group) | Zürich (region) |
Griffiths, Jane (JnJ 201706– Global Head of Actelion) | President/Director/Head Business Group/Unit/Division | Johnson & Johnson (JnJ) (Group) | Northwestern Switzerland (region) |
Grimm, Jan (Neurimmune 201711 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Neurimmune AG | Zürich (region) |
Grob, Bernhard (Tecan 201011–201301 Head of Partnering Business LEFT 1/13) | Business Development Manager / Strategy Manager | Tecan (Group) | Zürich (region) |
Groen, Jan (Intravacc 202005– before Novigenix + MDxHealth/OncoMethylome CEO before Agendia + Focus Diagnostics) | Chief Executive Officer (CEO) | Novigenix S.A. | Région Lémanique (region) |
Gromo, Gianni (Versant Ventures 201404 Venture Partner) | Venture Partner | Versant Ventures | California (federal state) |
Gruner, Luc (Evolva 201409– Chief Commerical Officer) | Chief Commercial Officer (CCO) | Lallemand (Group) | Northwestern Switzerland (region) |
Gueller, Rolf (Chemspeed Technologies 202401 CEO + Founder) | Chief Executive Officer (CEO) | Bruker (Group) | Northwestern Switzerland (region) |
Guenter, Andre (Sias AG 201510 CEO) | Chief Executive Officer (CEO) | Tecan (Group) | Zürich (region) |
Guichard, Christophe (Netris Pharma 202211 CFO + Eclosion2 202211 General Partner + CFO) | Chief Financial Officer (CFO) | Netris Pharma S.A.S. | Auvergne-Rhône-Alpes (region) |
Guidotti, Andrea (Simulands 202303 CEO) | Chief Executive Officer (CEO) | Simulands AG | Central Switzerland (region) |
Guillarme, Davy (Univ Geneva 201704) | Researcher (university / research institute) | University of Geneva (Université de Genève, UNIGE) | Région Lémanique (region) |
Gulfo, Adele (Roivant 201910 Chief of Commerical Development at Roivant Pharma) | Chief Commercial Officer (CCO) | Roivant (Group) | Northwestern Switzerland (region) |
Gulyani, Meeta (Merck (DE) 201403– Head of Strategy + Global Franchises at Merck Serono before Roche + Sanofi) | Business Development Manager / Strategy Manager | Merck (DE) (Group) | Hessen (Hesse) (federal state) |
Gundel, Dietmar (Genetics Company 200301– VP Corp + BusDev before CallistoGen CFO) | Business Development Manager / Strategy Manager | Genetics Company Inc., The | Zürich (region) |
Guye, Patrick (InSphero 201703 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | InSphero (Group) | Zürich (region) |
Gygax, Rudolf (Ruedi) (Novartis Venture Fund 200601 Managing Director) | Managing Director | Novartis (Group) | Northwestern Switzerland (region) |
Haag, Toralf (Voith 201810 Chairman Board of Management joined 201610 as CFO before CFO at Lonza Group) | Chief Financial Officer (CFO) | Voith (Group) | Germany (state/region unspecified) |
Haak, Stefan (Mysthera Therapeutics 202308 SVP RnD + Co-Founder) | Research & Development Manager | Mysthera Therapeutics AG | Northwestern Switzerland (region) |
Haas, Franz-Werner (LimmaTech Biologics 202307– CEO before CureVac + Sygnis Pharma + Lion BIoscience + Sirona Dental) | Chief Executive Officer (CEO) | LimmaTech Biologics AG | Zürich (region) |
Hadvary, Paul (Arpida 200803 Head of Developm) | n. a. | Lallemand (Group) | Northwestern Switzerland (region) |
Hadzhipetrova, Rositsa (InSphero 202303 Marketing Manager) | Sales Manager / Marketing Manager | InSphero (Group) | Zürich (region) |
Haefele, Mark (UBS 201604 Global Chief Investment Officer at UBS Wealth Management) | Investment Manager | UBS (Group) | Switzerland_other |
Haefeli, Roland (Actelion 201105 VP Head Investor Relations + Public Affairs) | Public Relations Manager / Investor Relations Manager | Johnson & Johnson (JnJ) (Group) | Northwestern Switzerland (region) |
Hafen, Ernst (EvalueScience 201104 CEO + Genetics Co + ETH Zürich) | Chief Executive Officer (CEO) | EvalueScience Ltd. | Zürich (region) |
Hagander, Michael (Microcaps 202101 Co-CEO + Co-Founder) | Chief Executive Officer (CEO) | Microcaps AG | Zürich (region) |
Halazonetis, Thanos (Univ Geneva 202004 Professor) | Professor | University of Geneva (Université de Genève, UNIGE) | Région Lémanique (region) |
Hale, Karen L. (Novartis 202105– Chief Legal Officer before AbbVie + Abbott + Sidley & Austin) | General Counsel / Chief Legal Officer (CLO) | Novartis (Group) | Northwestern Switzerland (region) |
Hall, Matthew (SimplicityBio SA 201610 CSO + Co-Founder) | n. a. | SimplicityBio S.A. | Région Lémanique (region) |
Halpert, Liat (Scinai Immunotherapeutics 202402– Head of BusDev + Sales before 14 years at Novartis) | Business Development Manager / Strategy Manager | Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) | Israel_o |
Hammel, Oliver (DKSH 201904 Managing Director, Business Unit Technology, DKSH China) | Managing Director | DKSH (Group) | Zürich (region) |
Hammond, Janet (Roche 201402 Head Infectious Disease at Roche pRED) | Research & Development Manager | Roche (Group) | Northwestern Switzerland (region) |
Hanan, Christopher C. (Tecan 2005– Senior VP BusDev + Corporate Communications joined Tecan 2004) | Business Development Manager / Strategy Manager | Tecan (Group) | Zürich (region) |
Hansen, Jakob Dynnes (Acesion Pharma 201611– CFO before Evolva + Nuevolution + Zealand Pharma + Novo Nordisk) | Chief Financial Officer (CFO) | Lallemand (Group) | Northwestern Switzerland (region) |
Hansen, Jørgen (Evolva 201304–201712 promoted CSO before run Danish research TO STEP DOWN unitl end 2017) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Lallemand (Group) | Northwestern Switzerland (region) |
Harboe-Schmidt, Peter (Vandria 202312 Head of Business Development + Finance) | Business Development Manager / Strategy Manager | Vandria S.A. | Région Lémanique (region) |
Harding, Alex (CRISPR Therapeutics 202301– Head BusDev before Remix Theraepeutics + Atlas Venture) | Business Development Manager / Strategy Manager | CRISPR Therapeutics (Group) | Northwestern Switzerland (region) |
Harrington-Smith, Kristen (ADC Therapeutics 202211– CCO before Immunogen + Novartis Pharmaceuticals) | Chief Commercial Officer (CCO) | ADC Therapeutics (Group) | Région Lémanique (region) |
Harris, Michael (Sigma-Aldrich 201104 VP Managing Director EMEA) | Regional manager | Merck (DE) (Group) | Eastern Switzerland (region) |
Harrison, Clark (Biocartis 201201– COO before Leica Biosystems VP Global Operations) | Chief Operating Officer (COO) | Biocartis (Group) | Région Lémanique (region) |
Hashemi, Brian B. (Novigenix 202211 CEO + Executive Chairman) | Chief Executive Officer (CEO) | Novigenix S.A. | Région Lémanique (region) |
Hashimoto, Lara (Sophia Genetics 202004– CBO before Roche Diagnostics) | Chief Business Officer (CBO) | Sophia Genetics (Group) | Région Lémanique (region) |
Hassler, Werner (Biotrend / Anawa Trading 201204 CEO) | Chief Executive Officer (CEO) | Biotrend (Group) | Switzerland_other |
Hauck, Gerrit (Basilea 201807– CTO before Sanofi) | Chief Technology/Technical Officer (CTO) | Basilea (Group) | Northwestern Switzerland (region) |
Hays, Anne (Lonza 201412 Head Custom Development Services Organisation) | Business Development Manager / Strategy Manager | Lonza (Group) | Northwestern Switzerland (region) |
Hecht, Thomas (Delenex 201105 Board Chairman + Affimed 201112 Board Chairman) | Board member, non-executive | Athenex (Group) | Zürich (region) |
Hediard, Florent (SGS 201610 Life Sciences Marketing Director Agriculture + Food + Life) | Sales Manager / Marketing Manager | SGS (Group) | Région Lémanique (region) |
Hédou, Gaël (Relief Therapeutics 201610 COO) | Chief Operating Officer (COO) | Relief Therapeutics (Group) | Région Lémanique (region) |
Heim, Jutta (Evolva –201304 CSO STEPPED DOWN 4/13 before CTO before Basilea CSO + Novartis) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Lallemand (Group) | Northwestern Switzerland (region) |
Heimbrook, David (Roche 200310) | n. a. | Roche (Group) | Northwestern Switzerland (region) |
Heintze, Déborah (Lunaphore Technologies 201404– COO + Co-Founder) | Chief Operating Officer (COO) | Bio-Techne (Group) | Région Lémanique (region) |
Heinze-Krauss, Ingrid (Basilea 2000–201601 joined at founding 2000 + will retire 201601) | Chief Technology/Technical Officer (CTO) | Basilea (Group) | Northwestern Switzerland (region) |
Heinzen, Christoph (Alicon AG 200810 CEO) | Chief Executive Officer (CEO) | Alicon AG | Zürich (region) |
Helbling, Paul (Dualsystems Biotech 201309 Business Development Sales and Marketing) | Business Development Manager / Strategy Manager | Dualsystems Biotech (Group) | Zürich (region) |
Helfenstein, Roland (Numab 2011– CFO) | Chief Financial Officer (CFO) | Numab (Group) | Zürich (region) |
Heller, Barbara (Santhera 200701 CFO) | Chief Financial Officer (CFO) | Santhera (Group) | Northwestern Switzerland (region) |
Heller, Damian (Basilea 201708– General Counsel + Corp Secretary joined 2015 before Novartis Pharma + Syngenta) | General Counsel / Chief Legal Officer (CLO) | Basilea (Group) | Northwestern Switzerland (region) |
Heller, Manfred (Univ Bern 201109 Head Proteomics + Mass Spec Core Facility) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Bern | Espace Mittelland (region) |
Henchoz, Stéphane (Auven Therapeutics 201409– Director of Finance at ADC Therapeutics before Merck Serono) | Chief Financial Officer (CFO) | ADC Therapeutics (Group) | Région Lémanique (region) |
Henco, Karsten (HS LifeSciences 200901 President + former founding investor of Qiagen + Evotec et al) | Investment Manager | HS LifeSciences (Group) | Zürich (region) |
Herklots, Hans (LifeSci 201805 LifeSci Advisors before Carpicorn One + TiGenix) | Public Relations Manager / Investor Relations Manager | LifeSci (Group) | New York (federal state) |
Hernando Ariza, Ana (Bionomous 202208 COO + Co-Founder) | Chief Operating Officer (COO) | Bionomous S.A. | Région Lémanique (region) |
Herrendorff, Ruben (Polyneuron 201805 CEO + Co-Founder) | Chief Executive Officer (CEO) | Polyneuron Pharmaceuticals AG | Northwestern Switzerland (region) |
Herrmann, Andreas (Valerius Biopharma 201805 CEO + Founder before Alvotech + Celonic + Baliopharm + Synimmune + Cardion) | Chief Executive Officer (CEO) | Valerius Biopharma AG | Northwestern Switzerland (region) |
Hertig, Christina (Galenica 201112 Head Corporate Communications) | Public Relations Manager / Investor Relations Manager | Galenica (Group) | Espace Mittelland (region) |
Heyse, Stephan (Genedata 200701 Head of Genedata Screener) | Product Manager (personnel) | Genedata (Group) | Northwestern Switzerland (region) |
Hildinger, Markus (ExcellGene 200905 CBO) | Chief Business Officer (CBO) | ExcellGene S.A. | Région Lémanique (region) |
Hilvert, Donald (ETH Zürich 201310 Professor at Lab for Organic Chemistry) | Professor | ETH Zürich (ETHZ) | Zürich (region) |
Hippe, Alan (Roche 201104– CFO before ThyssenKrupp + Continental + Fraport) | Chief Financial Officer (CFO) | Roche (Group) | Northwestern Switzerland (region) |
Hirawat, Samit (BMS 202108 CMO before Novartis 201710 EVP + Head Global Drug Development at Novartis Oncology) | Chief Medical Officer (CMO) | Bristol Myers Squibb (BMS) (Group) | New York (federal state) |
Hirsbrunner, Fritz (Galenica –201112 CFO + Deputy CEO ) | Chief Financial Officer (CFO) | Galenica (Group) | Espace Mittelland (region) |
Ho, Tony (CRISPR Therapeutics 201708– EVP + Head RnD) | n. a. | CRISPR Therapeutics (Group) | Northwestern Switzerland (region) |
Hobmeier, Mike (Verve Capital Partners 202206) | n. a. | Verve Capital Partners AG (Verve Ventures, formerly investiere.ch) | Central Switzerland (region) |
Hochstrasser, Denis (University Geneva 201005 Professor HUG Head Dept Genetic and Laboratory Medicine) | Professor | University of Geneva (Université de Genève, UNIGE) | Région Lémanique (region) |
Hock, Christoph (Neurimmune 201808– CMO before Co-Founder + Board Member main org Univ Zurich) | Chief Medical Officer (CMO) | Neurimmune AG | Zürich (region) |
Hoehnel, Sylke (Sun Bioscience 202310 Co-CEO + Co-Founder) | Chief Executive Officer (CEO) | Région Lémanique (region) | |
Hoenlinger, Sheida (SGS 201610 Director Life Sciences Germany) | President/Director/Head Business Group/Unit/Division | SGS (Group) | Région Lémanique (region) |
Hof, Catherine (Polyphor 201608 Corporate Communications) | Public Relations Manager / Investor Relations Manager | Spexis (Group) | Northwestern Switzerland (region) |
Hofmeister, Anton (STMicroelectronics 200509) | n. a. | STMicroelectronics (Group) | Région Lémanique (region) |
Holdener, Eduard (Ed) (Novimmune 201512– CEO before Roche CMO) | Chief Executive Officer (CEO) | Novimmune S.A. | Région Lémanique (region) |
Holzmeister, Johannes (Dinaqor 202009 CEO + Co-Founder + Cardiorentis AG 201409 CEO + CMO) | Chief Executive Officer (CEO) | Dinaqor (Group) | Central Switzerland (region) |
Hooftman, Leon (Polyphor 201503– CMO before Synthon BV + Chroma Therapeutics Ltd + Celltech + Roche) | Chief Medical Officer (CMO) | Spexis (Group) | Northwestern Switzerland (region) |
Hopfgartner, Gérard (Univ Geneva 201003 Professor) | Professor | University of Geneva (Université de Genève, UNIGE) | Région Lémanique (region) |
Hopkins, Jill (Novartis 202107 Global Develpment Head Ophthalmology at Novartis Pharmaceuticals) | President/Director/Head Business Group/Unit/Division | Novartis (Group) | Northwestern Switzerland (region) |
Hoppenot, Hervé (Incyte 201401– CEO before Novartis President Oncology) | Chief Executive Officer (CEO) | Incyte Corporation (Group) | Delaware (federal state) |
Hornemann, Thorsten (Lipidon 201808 CEO) | Chief Executive Officer (CEO) | Lipidon AG (Lipidon Analytics) | Zürich (region) |
Horning, Sandra (Roche 201401–201912 CMO + Head Global Product Development joined 2009 RETIRED 12/19) | Chief Medical Officer (CMO) | Roche (Group) | Northwestern Switzerland (region) |
Hornstein, Jörg (Lundbeck 202209– CFO before AC Immune + Theo Müller Group + Merck KGaA) | Chief Financial Officer (CFO) | Lundbeck (Group) | Hovedstaden |
Hosang, Markus (BioMedPartners 201108 General Partner) | General Partner (venture partner) | BioMedPartners (Group) | Northwestern Switzerland (region) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top